Problems in assessment of acute melatonin overdose

Southern Medical Journal

Volumn 90, Issue 4, 1997, Pages 451-453

  Holliman, Billie J ^a,b,c   Chyka, Peter A ^a,b  

^a University of Tennessee ^*

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Southern Poison Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; FLUMAZENIL; MELATONE; MELATONIN; NALOXONE; SEDATIVE AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISORIENTATION; DRUG ANTAGONISM; DRUG OVERDOSE; HUMAN; LETHARGY; MALE; PATIENT MONITORING; PROSTATE SURGERY; SEDATION; SPINAL ANESTHESIA;

EID: 0030976641     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199704000-00020     Document Type: Article

References (19)

1. Turek FW: Melatonin hype hard to swallow. Nature 1996; 379:295-296
2. Anonymous: Herbal roulette. Consumer Reports 1995; 60:698-705
3. Waldhauser F, Lynch HJ, Wurtman RJ: Melatonin in human body fluids: clinical significance. The Pineal Gland. Reiter RJ (ed). New York, Raven Press, 1984, pp 345-370
4. Melatonin. DRUGDEX System. Gelman CR, Rumack BH, Hess AJ (eds). Englewood, Colo, Micromedex Inc, (Edition expires 8/31/96)
5. Stankov B, Fraschini F, Reiter RJ: Melatonin binding sites in the central nervous system. Brain Res Rev 1991; 16:245-256
6. Reiter RJ, Melchiorri D, Sewerynek E, et al: A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11
7. Dawson D, Encel N: Melatonin and sleep in humans. J Pineal Res 1993; 15:1-15
8. Sack RL, Lewy AJ, Blood ML, et al: Melatonin administration in blind people: phase advances and entrainment. J Biol Rhythms 1991; 6:249-261
9. Anonymous: Melatonin. Med Lett Drugs Ther 1995; 37:111-112
10. Dahlitz M, Alvarez B, Vignau J, et al: Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337:1121-1124
11. Dollins AB, Zhdanova IV, Wurtman RJ, et al: Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994; 91:1824-1828
12. Zhdanova IV, Wurtman RJ, Lynch HJ, et al: Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57:552-558
13. Garfinkel D, Laudon M, Nof D, et al: Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346:541-544
14. Anonymous: Melatonin. The Lawrence Review of Natural Products. Hebel SK (ed). St. Louis, Facts and Comparisons, 1996, p 4
15. Papavasiliou PS, Cotzias GC, Düby SE, et al: Melatonin and parkinsonism (Letter). JAMA 1972; 221:88-89
16. 3H]flunitrazepam binding. Neuroreport 1993; 4:987-990
17. Golombek DA, Escolar E, Burin LJ, et al: Chronopharmacy of melatonin: inhibition by benzodiazepine antagonism. Chronobiol Int 1992; 9:124-131
18. Dietary Supplement Health and Education Act of 1994. 103-417 USC 108 § 4325
19. Regulation of dietary supplements, proposed rules. (58 CFR 33690-33700). Federal Register June 18, 1993; 58(116):33690-33700